Biblio

Author Title [ Type(Desc)] Year
Filters: Author is Mirzaei, Hamed  [Clear All Filters]
Journal Article
Heydari Z, Moeinvaziri F, Mirazimi SMohammad A, Dashti F, Smirnova O, Shpichka A, Mirzaei H, Timashev P, Vosough M. Alteration in DNA methylation patterns: Epigenetic signatures in gastrointestinal cancers. Eur J Pharmacol. 2024:176563.
Seydi H, Nouri K, Rezaei N, Tamimi A, Hassan M, Mirzaei H, Vosough M. Autophagy orchestrates resistance in hepatocellular carcinoma cells. Biomed Pharmacother. 2023;161:114487.
Pourhanifeh MHossein, Vosough M, Mahjoubin-Tehran M, Hashemipour M, Nejati M, Abbasi-Kolli M, Sahebkar A, Mirzaei H. Autophagy-related microRNAs: Possible regulatory roles and therapeutic potential in and gastrointestinal cancers. Pharmacol Res. 2020:105133.
Rarani FZamani, Rarani MZamani, Hamblin MR, Rashidi B, Hashemian SMohammad R, Mirzaei H. Comprehensive overview of COVID-19-related respiratory failure: focus on cellular interactions. Cell Mol Biol Lett. 2022;27(1):63.
Rajabi A, Nejati M, Homayoonfal M, Arj A, Razavi ZSadat, Ostadian A, Mohammadzadeh B, Vosough M, Karimi M, Rahimian N, et al. Doxorubicin-loaded zymosan nanoparticles: Synergistic cytotoxicity and modulation of apoptosis and Wnt/β-catenin signaling pathway in C26 colorectal cancer cells. Int J Biol Macromol. 2023:128949.
Halajzadeh J, Milajerdi A, Reiner Ž, Amirani E, Kolahdooz F, Barekat M, Mirzaei H, Mirhashemi SMehdi, Asemi Z. Effects of resistant starch on glycemic control, serum lipoproteins and systemic inflammation in patients with metabolic syndrome and related disorders: A systematic review and meta-analysis of randomized controlled clinical trials. Crit Rev Food Sci Nutr. 2019:1-13.
Zahmatkesh E, Khoshdel-Rad N, Mirzaei H, Shpichka A, Timashev P, Mahmoudi T, Vosough M. Evolution of organoid technology: Lessons learnt in Co-Culture systems from developmental biology. Dev Biol. 2021.
Fitzmaurice C, Abate D, Abbasi N, Abbastabar H, Abd-Allah F, Abdel-Rahman O, Abdelalim A, Abdoli A, Abdollahpour I, Abdulle ASM, et al. Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017: A Systematic Analysis for the Global Burden of Disease Study. JAMA Oncol. 2019.
Khosravi S, Salehi M, Ramezanzadeh M, Mirzaei H, Salehi R. Novel Multiplex Fluorescent PCR-Based Method for HLA Typing and Preimplantational Genetic Diagnosis of β-Thalassemia. Arch Med Res. 2016;47(4):293-298.
Goleij P, Sanaye PMajma, Babamohamadi M, Tabari MAmin Khaze, Amirian R, Rezaee A, Mirzaei H, Kumar APrem, Sethi G, Sadreddini S, et al. Phytostilbenes in lymphoma: Focuses on the mechanistic and clinical prospects of resveratrol, pterostilbene, piceatannol, and pinosylvin. Leuk Res. 2024;138:107464.
Mirzaei H, Salehi H, Oskuee RKazemi, Mohammadpour A, Mirzaei HReza, Sharifi MReza, Salarinia R, Darani HYousofi, Mokhtari M, Masoudifar A, et al. Retraction notice to "The therapeutic potential of human adipose-derived mesenchymal stem cells producing CXCL10 in a mouse melanoma lung metastasis model" [Cancer Lett. 419 (2018) 30-39]. Cancer Lett. 2024:216670.
Ashrafizadeh M, Zarrabi A, Hashemipour M, Vosough M, Najafi M, Shahinozzaman M, Hushmandi K, Khan H, Mirzaei H. Sensing the scent of death: Modulation of microRNAs by curcumin in gastrointestinal cancers. Pharmacol Res. 2020:105199.
Vakili-Ghartavol R, Mombeiny R, Salmaninejad A, Sorkhabadi SMahdi Reza, Faridi-Majidi R, Jaafari MReza, Mirzaei H. Tumor-associated macrophages and epithelial-mesenchymal transition in cancer: Nanotechnology comes into view. J Cell Physiol. 2018.
Asadian S, Mirzaei H, Kalantari BAziz, Davarpanah MReza, Mohamadi M, Shpichka A, Nasehi L, Es HAboulkheyr, Timashev P, Najimi M, et al. β-radiating Radionuclides in Cancer Treatment, Novel Insight into Promising Approach. Pharmacol Res. 2020:105070.